K. Cohen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
K. I. Barnes1
L. Workman1
J. S. Van der Walt1
1K. I. Barnes
1L. Workman
1J. S. Van der Walt
1L. Wiesner
Learn More
BACKGROUND Artemether-lumefantrine is currently the most widely recommended treatment of uncomplicated malaria. Lopinavir-based antiretroviral therapy is the commonly recommended second-line HIV treatment. Artemether and lumefantrine are metabolised by cytochrome P450 isoenzyme CYP3A4, which lopinavir/ritonavir inhibits, potentially causing clinically(More)
  • 1